Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-30

Clinical Trial Update: Predictors of Aspirin Failure in Preeclampsia Prevention [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 trial at Rockefeller University is evaluating predictors of aspirin failure for preventing preeclampsia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Rockefeller University | Conditions: Preeclampsia | EARLY_Phase 1 | Status: RECRUITING